WHO Member States Dig into Nitty Gritty of Proposed International Pandemic Accord 18/07/2022 Elaine Ruth Fletcher The first day of WHO member state talks on a proposed new Pandemic Convention or Treaty opened with broad agreement that the new legal instrument should complement – but not repeat – provisions of the existing International Health Regulations – while respecting national sovereignty in terms of public health responses. But the hours of debate […] Continue reading -> COVID-19 Pandemic Fuels Largest Backslide of Routine Childhood Vaccinations, Leaving 25 Million Infants Without Vaccines 15/07/2022 Raisa Santos The World Health Organization and UNICEF have sounded the alarm on the largest sustained decline in global childhood vaccinations in approximately 30 years, with 25 million infants missing out on lifesaving routine vaccines. The percentage of children who received three doses of vaccine against diphtheria, tetanus and pertussis (DTP3) – a marker for immunization coverage […] Continue reading -> Race to Develop Omicron-proof Boosters Before Northern Winter 14/07/2022 Kerry Cullinan Vaccine manufacturers are in a race to develop or tweak COVID-19 vaccines to address the Omicron variants that are sweeping through the globe – and get them ready for use as boosters when the weather cools in the northern hemisphere. More infectious Omicron strains BA.4 and BA.5 have become dominant in many parts of the […] Continue reading -> Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> WHO: COVID-19 Global Health Emergency Continuing; Monkeypox Cases Increase by 50% 12/07/2022 Elaine Ruth Fletcher With a surge in cases and the rapid rise of new subvariants, the COVID-19 pandemic continues to be a global health emergency posing significant risks to public health, a WHO committee of public health experts has concluded. The statement by the COVID-19 Emergency Committee, was published Tuesday, four days after experts gathered for their 12th […] Continue reading -> UN Human Rights Council’s Resolution on Access to Medicines and Vaccines Welcomed by Civil Society 11/07/2022 Elaine Ruth Fletcher Citizens and NGOs welcomed the United Nations Human Rights Council’s adoption of a much-debated draft resolution that calls on nations to ensure everyone has access to medicines and vaccines. The resolution was adopted by consensus Friday shortly before the close of the HRC’s 50th session, sending what proponents called a “clear message” that access to […] Continue reading -> Some 1.1 Billion COVID-19 Vaccine Doses Likely Wasted Since Rollout Began 11/07/2022 Editorial team Some 1.1 billion COVID-19 vaccines are likely to have been wasted since the global rollout began, according to new findings by Airfinity, a global health surveillance firm. Airfinity’s analysis, released Monday, assumed a 10% wastage rate from June 2021 when global dose sharing began. This rate is taken from confirmed wastage in the United States […] Continue reading -> European Medicines Agency Recommends Second COVID Booster for People Over 60 – as WHO Ponders Status of COVID Emergency 08/07/2022 Elaine Ruth Fletcher With cases of Omicron BA.4 and BA.5 soaring in Europe and around the world, the European Medicines Agency (EMA) recommends everyone 60 and older get a second COVID-19 booster shot. EMA’s recommendation came shortly before WHO reconvened its COVID Emergency Committee on Friday to reconsider its global recommendations for the pandemic – and if the […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Pandemic Fuels Largest Backslide of Routine Childhood Vaccinations, Leaving 25 Million Infants Without Vaccines 15/07/2022 Raisa Santos The World Health Organization and UNICEF have sounded the alarm on the largest sustained decline in global childhood vaccinations in approximately 30 years, with 25 million infants missing out on lifesaving routine vaccines. The percentage of children who received three doses of vaccine against diphtheria, tetanus and pertussis (DTP3) – a marker for immunization coverage […] Continue reading -> Race to Develop Omicron-proof Boosters Before Northern Winter 14/07/2022 Kerry Cullinan Vaccine manufacturers are in a race to develop or tweak COVID-19 vaccines to address the Omicron variants that are sweeping through the globe – and get them ready for use as boosters when the weather cools in the northern hemisphere. More infectious Omicron strains BA.4 and BA.5 have become dominant in many parts of the […] Continue reading -> Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> WHO: COVID-19 Global Health Emergency Continuing; Monkeypox Cases Increase by 50% 12/07/2022 Elaine Ruth Fletcher With a surge in cases and the rapid rise of new subvariants, the COVID-19 pandemic continues to be a global health emergency posing significant risks to public health, a WHO committee of public health experts has concluded. The statement by the COVID-19 Emergency Committee, was published Tuesday, four days after experts gathered for their 12th […] Continue reading -> UN Human Rights Council’s Resolution on Access to Medicines and Vaccines Welcomed by Civil Society 11/07/2022 Elaine Ruth Fletcher Citizens and NGOs welcomed the United Nations Human Rights Council’s adoption of a much-debated draft resolution that calls on nations to ensure everyone has access to medicines and vaccines. The resolution was adopted by consensus Friday shortly before the close of the HRC’s 50th session, sending what proponents called a “clear message” that access to […] Continue reading -> Some 1.1 Billion COVID-19 Vaccine Doses Likely Wasted Since Rollout Began 11/07/2022 Editorial team Some 1.1 billion COVID-19 vaccines are likely to have been wasted since the global rollout began, according to new findings by Airfinity, a global health surveillance firm. Airfinity’s analysis, released Monday, assumed a 10% wastage rate from June 2021 when global dose sharing began. This rate is taken from confirmed wastage in the United States […] Continue reading -> European Medicines Agency Recommends Second COVID Booster for People Over 60 – as WHO Ponders Status of COVID Emergency 08/07/2022 Elaine Ruth Fletcher With cases of Omicron BA.4 and BA.5 soaring in Europe and around the world, the European Medicines Agency (EMA) recommends everyone 60 and older get a second COVID-19 booster shot. EMA’s recommendation came shortly before WHO reconvened its COVID Emergency Committee on Friday to reconsider its global recommendations for the pandemic – and if the […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Race to Develop Omicron-proof Boosters Before Northern Winter 14/07/2022 Kerry Cullinan Vaccine manufacturers are in a race to develop or tweak COVID-19 vaccines to address the Omicron variants that are sweeping through the globe – and get them ready for use as boosters when the weather cools in the northern hemisphere. More infectious Omicron strains BA.4 and BA.5 have become dominant in many parts of the […] Continue reading -> Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> WHO: COVID-19 Global Health Emergency Continuing; Monkeypox Cases Increase by 50% 12/07/2022 Elaine Ruth Fletcher With a surge in cases and the rapid rise of new subvariants, the COVID-19 pandemic continues to be a global health emergency posing significant risks to public health, a WHO committee of public health experts has concluded. The statement by the COVID-19 Emergency Committee, was published Tuesday, four days after experts gathered for their 12th […] Continue reading -> UN Human Rights Council’s Resolution on Access to Medicines and Vaccines Welcomed by Civil Society 11/07/2022 Elaine Ruth Fletcher Citizens and NGOs welcomed the United Nations Human Rights Council’s adoption of a much-debated draft resolution that calls on nations to ensure everyone has access to medicines and vaccines. The resolution was adopted by consensus Friday shortly before the close of the HRC’s 50th session, sending what proponents called a “clear message” that access to […] Continue reading -> Some 1.1 Billion COVID-19 Vaccine Doses Likely Wasted Since Rollout Began 11/07/2022 Editorial team Some 1.1 billion COVID-19 vaccines are likely to have been wasted since the global rollout began, according to new findings by Airfinity, a global health surveillance firm. Airfinity’s analysis, released Monday, assumed a 10% wastage rate from June 2021 when global dose sharing began. This rate is taken from confirmed wastage in the United States […] Continue reading -> European Medicines Agency Recommends Second COVID Booster for People Over 60 – as WHO Ponders Status of COVID Emergency 08/07/2022 Elaine Ruth Fletcher With cases of Omicron BA.4 and BA.5 soaring in Europe and around the world, the European Medicines Agency (EMA) recommends everyone 60 and older get a second COVID-19 booster shot. EMA’s recommendation came shortly before WHO reconvened its COVID Emergency Committee on Friday to reconsider its global recommendations for the pandemic – and if the […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> WHO: COVID-19 Global Health Emergency Continuing; Monkeypox Cases Increase by 50% 12/07/2022 Elaine Ruth Fletcher With a surge in cases and the rapid rise of new subvariants, the COVID-19 pandemic continues to be a global health emergency posing significant risks to public health, a WHO committee of public health experts has concluded. The statement by the COVID-19 Emergency Committee, was published Tuesday, four days after experts gathered for their 12th […] Continue reading -> UN Human Rights Council’s Resolution on Access to Medicines and Vaccines Welcomed by Civil Society 11/07/2022 Elaine Ruth Fletcher Citizens and NGOs welcomed the United Nations Human Rights Council’s adoption of a much-debated draft resolution that calls on nations to ensure everyone has access to medicines and vaccines. The resolution was adopted by consensus Friday shortly before the close of the HRC’s 50th session, sending what proponents called a “clear message” that access to […] Continue reading -> Some 1.1 Billion COVID-19 Vaccine Doses Likely Wasted Since Rollout Began 11/07/2022 Editorial team Some 1.1 billion COVID-19 vaccines are likely to have been wasted since the global rollout began, according to new findings by Airfinity, a global health surveillance firm. Airfinity’s analysis, released Monday, assumed a 10% wastage rate from June 2021 when global dose sharing began. This rate is taken from confirmed wastage in the United States […] Continue reading -> European Medicines Agency Recommends Second COVID Booster for People Over 60 – as WHO Ponders Status of COVID Emergency 08/07/2022 Elaine Ruth Fletcher With cases of Omicron BA.4 and BA.5 soaring in Europe and around the world, the European Medicines Agency (EMA) recommends everyone 60 and older get a second COVID-19 booster shot. EMA’s recommendation came shortly before WHO reconvened its COVID Emergency Committee on Friday to reconsider its global recommendations for the pandemic – and if the […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO: COVID-19 Global Health Emergency Continuing; Monkeypox Cases Increase by 50% 12/07/2022 Elaine Ruth Fletcher With a surge in cases and the rapid rise of new subvariants, the COVID-19 pandemic continues to be a global health emergency posing significant risks to public health, a WHO committee of public health experts has concluded. The statement by the COVID-19 Emergency Committee, was published Tuesday, four days after experts gathered for their 12th […] Continue reading -> UN Human Rights Council’s Resolution on Access to Medicines and Vaccines Welcomed by Civil Society 11/07/2022 Elaine Ruth Fletcher Citizens and NGOs welcomed the United Nations Human Rights Council’s adoption of a much-debated draft resolution that calls on nations to ensure everyone has access to medicines and vaccines. The resolution was adopted by consensus Friday shortly before the close of the HRC’s 50th session, sending what proponents called a “clear message” that access to […] Continue reading -> Some 1.1 Billion COVID-19 Vaccine Doses Likely Wasted Since Rollout Began 11/07/2022 Editorial team Some 1.1 billion COVID-19 vaccines are likely to have been wasted since the global rollout began, according to new findings by Airfinity, a global health surveillance firm. Airfinity’s analysis, released Monday, assumed a 10% wastage rate from June 2021 when global dose sharing began. This rate is taken from confirmed wastage in the United States […] Continue reading -> European Medicines Agency Recommends Second COVID Booster for People Over 60 – as WHO Ponders Status of COVID Emergency 08/07/2022 Elaine Ruth Fletcher With cases of Omicron BA.4 and BA.5 soaring in Europe and around the world, the European Medicines Agency (EMA) recommends everyone 60 and older get a second COVID-19 booster shot. EMA’s recommendation came shortly before WHO reconvened its COVID Emergency Committee on Friday to reconsider its global recommendations for the pandemic – and if the […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
UN Human Rights Council’s Resolution on Access to Medicines and Vaccines Welcomed by Civil Society 11/07/2022 Elaine Ruth Fletcher Citizens and NGOs welcomed the United Nations Human Rights Council’s adoption of a much-debated draft resolution that calls on nations to ensure everyone has access to medicines and vaccines. The resolution was adopted by consensus Friday shortly before the close of the HRC’s 50th session, sending what proponents called a “clear message” that access to […] Continue reading -> Some 1.1 Billion COVID-19 Vaccine Doses Likely Wasted Since Rollout Began 11/07/2022 Editorial team Some 1.1 billion COVID-19 vaccines are likely to have been wasted since the global rollout began, according to new findings by Airfinity, a global health surveillance firm. Airfinity’s analysis, released Monday, assumed a 10% wastage rate from June 2021 when global dose sharing began. This rate is taken from confirmed wastage in the United States […] Continue reading -> European Medicines Agency Recommends Second COVID Booster for People Over 60 – as WHO Ponders Status of COVID Emergency 08/07/2022 Elaine Ruth Fletcher With cases of Omicron BA.4 and BA.5 soaring in Europe and around the world, the European Medicines Agency (EMA) recommends everyone 60 and older get a second COVID-19 booster shot. EMA’s recommendation came shortly before WHO reconvened its COVID Emergency Committee on Friday to reconsider its global recommendations for the pandemic – and if the […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Some 1.1 Billion COVID-19 Vaccine Doses Likely Wasted Since Rollout Began 11/07/2022 Editorial team Some 1.1 billion COVID-19 vaccines are likely to have been wasted since the global rollout began, according to new findings by Airfinity, a global health surveillance firm. Airfinity’s analysis, released Monday, assumed a 10% wastage rate from June 2021 when global dose sharing began. This rate is taken from confirmed wastage in the United States […] Continue reading -> European Medicines Agency Recommends Second COVID Booster for People Over 60 – as WHO Ponders Status of COVID Emergency 08/07/2022 Elaine Ruth Fletcher With cases of Omicron BA.4 and BA.5 soaring in Europe and around the world, the European Medicines Agency (EMA) recommends everyone 60 and older get a second COVID-19 booster shot. EMA’s recommendation came shortly before WHO reconvened its COVID Emergency Committee on Friday to reconsider its global recommendations for the pandemic – and if the […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Medicines Agency Recommends Second COVID Booster for People Over 60 – as WHO Ponders Status of COVID Emergency 08/07/2022 Elaine Ruth Fletcher With cases of Omicron BA.4 and BA.5 soaring in Europe and around the world, the European Medicines Agency (EMA) recommends everyone 60 and older get a second COVID-19 booster shot. EMA’s recommendation came shortly before WHO reconvened its COVID Emergency Committee on Friday to reconsider its global recommendations for the pandemic – and if the […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts